ResMed (RMD) PT Raised to $200 at RBC Capital
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $231.36 -3.64%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
RBC Capital analyst Craig Wong-Pan raised the price target on ResMed (NYSE: RMD) to $200.00 (from $187.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- ResMed (RMD) PT Raised to $267 at KeyBanc Following Last Week's NDR
- Comstock Resources (CRK) PT Raised to $20 at Mizuho
- Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
